How to get Cancer Antigen CA19-9 quantitative detection Kit (TRIFA)?

CA19-9 (carbohydrate antigen 19-9, aswell alleged blight antigen 19-9[1] or sialylated Lewis (a) antigen) is a bump marker that is acclimated primarily in the administration of pancreatic cancer.
Uses
Guidelines from the American Society of Clinical Oncology abash the use of CA19-9 as a screening analysis for cancer, decidedly pancreatic cancer. The acumen is that the analysis may be falsely accustomed (false negative) in abounding cases, or abnormally animated in humans who accept no blight at all (false positive). The capital use of CA19-9 is accordingly to see whether a pancreatic bump is secreting it; if that is the case, afresh the levels should abatement if the bump is treated, and they may acceleration afresh if the ache recurs.
In humans with pancreatic masses, CA19-9 can be advantageous in appropriate amid blight and added diseases of the gland.
CA19-9 can be animated in abounding types of gastrointestinal cancer, such as colorectal cancer, esophageal blight and hepatocellular carcinoma. Apart from cancer, animated levels may aswell action in pancreatitis, cirrhosis, and diseases of the acerbity ducts. It can be animated in humans with obstruction of the acerbity ducts.
In patients who abridgement the Lewis antigen (a claret blazon protein on red claret cells), which is about 10% of the Caucasian population, CA19-9 is not expressed, even in those with ample tumors. This is because of a absence of a fucosyltransferase agitator that is bare to aftermath CA19-9 as able-bodied as the Lewis antigen.
More about: Cancer Antigen CA19-9 quantitative detection Kit (TRIFA) sale
Read more: chemical reagent